Frontlight ResearchEarly access
Pancreatic cancer trials in United States
405 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleSMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial
- Where
- Chicago
- Age
- 18 years and over
- People
- 125
- Run by
- Northwestern University
See details and how to joinNCT07748611 - Phase 1/2CompletedBOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours
- Where
- Santa Monica, Tampa
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Bold Therapeutics, Inc.
See details and how to joinNCT04421820 · EU 2024-517500-11-00 - Phase 1Taking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Houston, Lake Success, Los Angeles, Portland, West Valley City
- Age
- 18 years and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - Phase 1/2Taking peopleLead-212 PSV359 Therapy for Patients With Solid Tumors
- Where
- Cleveland, Columbus, Dallas, Houston, Kansas City, Lexington, Los Angeles, Madison, Miami, New York, Omaha, Pittsburgh, Rochester, St Louis
- Age
- 18 years to 90 years
- People
- 112
- Run by
- Perspective Therapeutics
See details and how to joinNCT06710756 - Phase 1/2Taking people[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- Where
- Dallas, New York
- Age
- 18 years to 80 years
- People
- 71
- Run by
- Blue Earth Diagnostics
See details and how to joinNCT07432633 - Phase 3Enrolling by invitationLong-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
- Where
- Bay Shore, Houston, Kettering, Memphis
- People
- 5,000
- Run by
- Exelixis
See details and how to joinNCT07620574 · EU 2026-525795-26-00 - Phase 1Taking peopleA Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 20
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07671339 - No phaseTaking peoplectDNA Assay in Patients With Resectable Pancreatic Cancer
- Where
- Oklahoma City, Tulsa
- Age
- 18 years to 99 years
- People
- 50
- Run by
- University of Oklahoma
See details and how to joinNCT05052671 - Phase 1Taking peopleFirst in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 40
- Run by
- ParVation Therapeutics, Inc.
See details and how to joinNCT07756281 - Phase 1Not yet taking people in United StatesDaraxonrasib in Resectable PDAC
- Where
- Boston
- Age
- 18 years and over
- People
- 30
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07898813 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Amarillo, Chattanooga, Dallas, Fairfax, Germantown, Los Angeles, Minneapolis, Nashville, New York, Pearland, Salt Lake City, Skokie, Wenatchee, Westbury, White Plains, Whittier
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 1Taking peopleA Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Where
- Boston, Durham, Fairfax, Houston, Nashville, New York, Orlando, San Antonio, St Louis, Tampa
- Age
- 18 years and over
- People
- 448
- Run by
- Alterome Therapeutics, Inc.
See details and how to joinNCT06835569 - Phase 1/2Taking peopleJAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
- Where
- Cleveland, Rochester, Salt Lake City, St Louis
- Age
- 18 years and over
- People
- 344
- Run by
- Jacobio Pharmaceuticals Co., Ltd.
See details and how to joinNCT06973564 - Phase 2Taking peopleA Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced Skin Toxicity in People With Pancreatic Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 122
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07895498 - Phase 1/2Taking peopleStudy to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
- Where
- Boston, Chapel Hill, Chicago, Denver, Fairfax, Houston, Indianapolis, Iowa City, Irving, Jacksonville, New York, Omaha, Rochester, Salt Lake City, Scottsdale, Washington D.C.
- Age
- 18 years and over
- People
- 183
- Run by
- Tango Therapeutics, Inc.
See details and how to joinNCT06922591 - Phase 3Taking peopleStudy of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Where
- Atlanta, Baltimore, Birmingham, Boston, Dallas, Durham, Fairfax, Hartford, Houston, Indianapolis, Jacksonville, Kansas City, La Jolla, Lakewood, Las Vegas, Lawrence, Longview, Los Angeles, Maumee, Miami, Miami Beach, Milwaukee, Nashville, New Brunswick, New York, Omaha, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Rochester, Sacramento, Salt Lake City, San Francisco, Scottsdale, Seattle, Sioux Falls, St. Petersburg
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07252232 · EU 2025-523495-23-00 - Phase 1/2Taking peopleANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
- Where
- Los Angeles, Plantation, San Antonio
- Age
- 18 years and over
- People
- 84
- Run by
- Anova Innovation Limited
See details and how to joinNCT07444541 - Phase 3Taking peopleThe Cancer of the Pancreas Screening-5 CAPS5)Study
- Where
- Ann Arbor, Baltimore, Boston, Cleveland, New Haven, New York, Philadelphia, Pittsburgh
- Age
- 18 years and over
- People
- 9,000
- Run by
- Johns Hopkins University
See details and how to joinNCT02000089 - Phase 1/2Taking peopleA Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Where
- Austin, Baton Rouge, Birmingham, Boston, Chattanooga, Cincinnati, Columbia, Dallas, Denver, East Syracuse, Fairfax, Flower Mound, Fort Myers, Hinsdale, Houston, Indianapolis, Jacksonville, Lake Success, Little Rock, Los Angeles, Maple Grove, Maumee, Memphis, Nashville, New York, Oklahoma City, Orlando, Philadelphia, Portland, Rochester, Salt Lake City, San Antonio, Santa Barbara, Santa Rosa, Sarasota, Scottsdale, Seattle, St Louis, Washington D.C., West Palm Beach
- Age
- 18 years and over
- People
- 542 worldwide
- Run by
- Artios Pharma Ltd
See details and how to joinNCT04657068 - Phase 1/2Taking peopleTesting the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 31
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07619521 - Phase 1Taking peopleA Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- Where
- Houston, San Antonio, Scottsdale
- Age
- 18 years and over
- People
- 30
- Run by
- SHY Therapeutics
See details and how to joinNCT07705334 - No phaseTaking peopleReach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial
- Where
- Boston
- Age
- 18 years and over
- People
- 80
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT07787156 - No phaseTaking peopleDisposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response
- Where
- Columbus, Nashville
- Age
- 19 years and over
- People
- 55
- Run by
- Ohio State University
See details and how to joinNCT04588025 - Phase 1Taking peopleAOH1996 for the Treatment of Refractory Solid Tumors
- Where
- Duarte, Long Beach, Scottsdale
- Age
- 18 years and over
- People
- 92
- Run by
- City of Hope Medical Center
See details and how to joinNCT05227326 - Phase 1Taking peopleTesting the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
- Where
- City of Saint Peters, Creve Coeur, Duarte, Irvine, Orange, Shiloh, St Louis
- Age
- 18 years and over
- People
- 24 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05687123